Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.
Hirakawa Y, Arima H, Webster R, Zoungas S, Li Q, Harrap S, Lisheng L, Hamet P, Mancia G, Poulter N, Neal B, Williams B, Rogers A, Woodward M, Chalmers J.
Hirakawa Y, et al. Among authors: neal b.
J Hypertens. 2016 Apr;34(4):781-7. doi: 10.1097/HJH.0000000000000841.
J Hypertens. 2016.
PMID: 26938813
Free article.
Clinical Trial.